Form 8-K HOLOGIC INC For: Jul 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Hologic (HOLX) PT Raised to $95 at JPMorgan
July 30, 2024 5:11 AM EDTJPMorgan analyst Casey Woodring raised the price target on Hologic (NASDAQ: HOLX) to $95.00 (from $91.00) while maintaining a Neutral rating.
The analyst comments "After the close, Hologic (HOLX) reported a F3Q24 beat, with revenues of $1.011B coming in above the Street of $1.001B and revenue dollar guidance of $992.5M-1.008B, representing+3.8% organic cc growth (vs. Street of +2.7%) and organic ex-COVID cc growth of +5.8% vs. guide of +4.0-5.6%. Moving down the P&L, adj. OPM of 31.2% came in slightly above the Street of 31.1%, with adj. EPS of $1.06 beating the Street of $1.02 and guide of... More



